These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A common BRCA1 mutation in the Ashkenazim. Goldgar DE; Reilly PR Nat Genet; 1995 Oct; 11(2):113-4. PubMed ID: 7550331 [No Abstract] [Full Text] [Related]
3. [BRCA1 and BRCA2--breast cancer susceptibility genes]. Dagan E; Gershoni-Baruch R Harefuah; 1997 Nov; 133(10):455-7. PubMed ID: 9418320 [No Abstract] [Full Text] [Related]
4. Breast & ovarian cancer. Issues in risk assessment. Caro SW Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719 [No Abstract] [Full Text] [Related]
5. Breast cancer susceptibility testing: realities in the post-genomic era. Friend SH Nat Genet; 1996 May; 13(1):16-7. PubMed ID: 8673095 [No Abstract] [Full Text] [Related]
6. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Struewing JP; Abeliovich D; Peretz T; Avishai N; Kaback MM; Collins FS; Brody LC Nat Genet; 1995 Oct; 11(2):198-200. PubMed ID: 7550349 [TBL] [Abstract][Full Text] [Related]
7. Progress made toward a diagnostic test for breast and ovarian cancer risk. Int J Fertil Menopausal Stud; 1995; 40(3):117. PubMed ID: 7663536 [No Abstract] [Full Text] [Related]
8. More on breast cancer guidelines. Nassar BA; Ludman MD; Costa MT; Welch JP; Butts CA; Love JR; Hogg H; Beis MJ CMAJ; 1998 Jun; 158(11):1429; author reply 1429-30. PubMed ID: 9629100 [No Abstract] [Full Text] [Related]
9. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations]. Ost E; Illiger HJ Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002 [No Abstract] [Full Text] [Related]
10. Breast cancer genes--what are the real risks? Easton D Nat Genet; 1997 Jul; 16(3):210-1. PubMed ID: 9207777 [No Abstract] [Full Text] [Related]
13. [A genetic test for breast cancer: curse or blessing?]. Sauer H Fortschr Med; 1995 Feb; 113(4):9-10. PubMed ID: 7713472 [No Abstract] [Full Text] [Related]
14. The genetics of breast cancer: can we use today's information? Bell NN Manag Care Interface; 1998 May; 11(5):52-6. PubMed ID: 10181553 [No Abstract] [Full Text] [Related]
15. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2. Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162 [No Abstract] [Full Text] [Related]
16. Breast cancer genes. Further enigmatic variations. Davies K Nature; 1995 Dec 21-28; 378(6559):762-3. PubMed ID: 8524409 [No Abstract] [Full Text] [Related]
17. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392 [TBL] [Abstract][Full Text] [Related]
18. Are BRCA1- and BRCA2-associated breast cancers different? Offit K J Clin Oncol; 2000 Nov; 18(21 Suppl):104S-6S. PubMed ID: 11060336 [No Abstract] [Full Text] [Related]
19. Molecular biology of breast cancer: integration of cellular and molecular concepts into therapeutic strategies. Konstadoulakis MM; Bland KI R I Med; 1995 Sep; 78(9):257-60. PubMed ID: 7579722 [No Abstract] [Full Text] [Related]
20. A human BRCA1 gene knockout. Boyd M; Harris F; McFarlane R; Davidson HR; Black DM Nature; 1995 Jun; 375(6532):541-2. PubMed ID: 7791869 [No Abstract] [Full Text] [Related] [Next] [New Search]